These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
322 related articles for article (PubMed ID: 25407022)
21. Common genetic variants associated with breast cancer in Korean women and differential susceptibility according to intrinsic subtype. Han W; Woo JH; Yu JH; Lee MJ; Moon HG; Kang D; Noh DY Cancer Epidemiol Biomarkers Prev; 2011 May; 20(5):793-8. PubMed ID: 21415360 [TBL] [Abstract][Full Text] [Related]
22. The role of classic risk factors and prothrombotic factor gene mutations in ischemic stroke risk development in young and middle-aged individuals. Supanc V; Sonicki Z; Vukasovic I; Solter VV; Zavoreo I; Kes VB J Stroke Cerebrovasc Dis; 2014 Mar; 23(3):e171-6. PubMed ID: 24189452 [TBL] [Abstract][Full Text] [Related]
23. A genome-wide association study of venous thromboembolism identifies risk variants in chromosomes 1q24.2 and 9q. Heit JA; Armasu SM; Asmann YW; Cunningham JM; Matsumoto ME; Petterson TM; De Andrade M J Thromb Haemost; 2012 Aug; 10(8):1521-31. PubMed ID: 22672568 [TBL] [Abstract][Full Text] [Related]
24. The association of idiopathic recurrent pregnancy loss with polymorphisms in hemostasis-related genes. Cao Y; Zhang Z; Xu J; Yuan W; Wang J; Huang X; Shen Y; Du J Gene; 2013 Nov; 530(2):248-52. PubMed ID: 23954867 [TBL] [Abstract][Full Text] [Related]
25. The association of inherited thrombophilia and intrauterine fetal death: a case-control study. Helgadottir LB; Skjeldestad FE; Jacobsen AF; Sandset PM; Jacobsen EM Blood Coagul Fibrinolysis; 2011 Dec; 22(8):651-6. PubMed ID: 22198364 [TBL] [Abstract][Full Text] [Related]
26. Endothelial protein C receptor 1651C/G polymorphism and soluble endothelial protein C receptor levels in women with idiopathic recurrent miscarriage. Dendana M; Messaoudi S; Hizem S; Jazia KB; Almawi WY; Gris JC; Mahjoub T Blood Coagul Fibrinolysis; 2012 Jan; 23(1):30-4. PubMed ID: 22036807 [TBL] [Abstract][Full Text] [Related]
27. Progesterone utilizes distinct membrane pools of tissue factor to increase coagulation and invasion and these effects are inhibited by TFPI. Henriquez S; Calderon C; Quezada M; Oliva B; Bravo ML; Aranda E; Kato S; Cuello MA; Gutiérrez J; Quest AF; Owen GI J Cell Physiol; 2011 Dec; 226(12):3278-85. PubMed ID: 21344386 [TBL] [Abstract][Full Text] [Related]
28. Oestrogen receptor alpha gene haplotype and postmenopausal breast cancer risk: a case control study. Wedrén S; Lovmar L; Humphreys K; Magnusson C; Melhus H; Syvänen AC; Kindmark A; Landegren U; Fermér ML; Stiger F; Persson I; Baron J; Weiderpass E Breast Cancer Res; 2004; 6(4):R437-49. PubMed ID: 15217512 [TBL] [Abstract][Full Text] [Related]
29. Genetic variation in TP53 and risk of breast cancer in a population-based case control study. Sprague BL; Trentham-Dietz A; Garcia-Closas M; Newcomb PA; Titus-Ernstoff L; Hampton JM; Chanock SJ; Haines JL; Egan KM Carcinogenesis; 2007 Aug; 28(8):1680-6. PubMed ID: 17449902 [TBL] [Abstract][Full Text] [Related]
30. Clarifying the PROGINS allele association in ovarian and breast cancer risk: a haplotype-based analysis. Pearce CL; Hirschhorn JN; Wu AH; Burtt NP; Stram DO; Young S; Kolonel LN; Henderson BE; Altshuler D; Pike MC J Natl Cancer Inst; 2005 Jan; 97(1):51-9. PubMed ID: 15632380 [TBL] [Abstract][Full Text] [Related]
31. Thrombin generation in first-degree relatives of patients with venous thromboembolism who have factor V Leiden. A pilot study. Couturaud F; Duchemin J; Leroyer C; Delahousse B; Abgrall JF; Mottier D; Thromb Haemost; 2008 Jan; 99(1):223-8. PubMed ID: 18217158 [TBL] [Abstract][Full Text] [Related]
32. Genetic polymorphisms in folate and alcohol metabolism and breast cancer risk: a case-control study in Thai women. Sangrajrang S; Sato Y; Sakamoto H; Ohnami S; Khuhaprema T; Yoshida T Breast Cancer Res Treat; 2010 Oct; 123(3):885-93. PubMed ID: 20180013 [TBL] [Abstract][Full Text] [Related]
33. Polymorphisms in the KDR and POSTN genes: association with breast cancer susceptibility and prognosis. Försti A; Jin Q; Altieri A; Johansson R; Wagner K; Enquist K; Grzybowska E; Pamula J; Pekala W; Hallmans G; Lenner P; Hemminki K Breast Cancer Res Treat; 2007 Jan; 101(1):83-93. PubMed ID: 16807673 [TBL] [Abstract][Full Text] [Related]
34. Three polymorphisms in promoter of protein C gene with endothelial protein c receptor gene and risk of venous thrombosis. Horakova K; Kolorz M; Bartosova L; Pechacek V; Wroblova K Blood Coagul Fibrinolysis; 2013 Dec; 24(8):814-7. PubMed ID: 24158116 [TBL] [Abstract][Full Text] [Related]
35. Genetic variation within the anticoagulant, procoagulant, fibrinolytic and innate immunity pathways as risk factors for venous thromboembolism. Heit JA; Cunningham JM; Petterson TM; Armasu SM; Rider DN; DE Andrade M J Thromb Haemost; 2011 Jun; 9(6):1133-42. PubMed ID: 21463476 [TBL] [Abstract][Full Text] [Related]
36. CASP8 polymorphisms, estrogen and progesterone receptor status, and breast cancer risk. Han S; Lee KM; Choi JY; Park SK; Lee JY; Lee JE; Noh DY; Ahn SH; Han W; Kim DH; Hong YC; Ha E; Yoo KY; Kang D Breast Cancer Res Treat; 2008 Jul; 110(2):387-93. PubMed ID: 17940865 [TBL] [Abstract][Full Text] [Related]
37. ABO blood group but not haemostasis genetic polymorphisms significantly influence thrombotic risk: a study of 180 homozygotes for the Factor V Leiden mutation. Procare-GEHT Group Br J Haematol; 2006 Dec; 135(5):697-702. PubMed ID: 17107352 [TBL] [Abstract][Full Text] [Related]
38. The role of polymorphisms in circadian pathway genes in breast tumorigenesis. Dai H; Zhang L; Cao M; Song F; Zheng H; Zhu X; Wei Q; Zhang W; Chen K Breast Cancer Res Treat; 2011 Jun; 127(2):531-40. PubMed ID: 20978934 [TBL] [Abstract][Full Text] [Related]
39. Polymorphisms of thrombophilic and vasoactive genes and severe preeclampsia: a pilot study. Tempfer CB; Jirecek S; Riener EK; Zeisler H; Denschlag D; Hefler L; Husslein PW J Soc Gynecol Investig; 2004 May; 11(4):227-31. PubMed ID: 15120696 [TBL] [Abstract][Full Text] [Related]
40. A Genome Wide Association Study on plasma FV levels identified PLXDC2 as a new modifier of the coagulation process. Thibord F; Hardy L; Ibrahim-Kosta M; Saut N; Pulcrano-Nicolas AS; Goumidi L; Civelek M; Eriksson P; Deleuze JF; Le Goff W; Trégouët DA; Morange PE J Thromb Haemost; 2019 Nov; 17(11):1808-1814. PubMed ID: 31271701 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]